Growth for India’s biotech sector has decelerated from the compound annual growth rate of 34% in the past five years to a 20% rate for 2007–2008, recording nearly $2.5 billion in revenues, according to a survey by the Association of Biotech Led Enterprises and Biospectrum magazine. The biotech sector is divided into five segments: biopharma, bioservices, bioagri, bioindustrial and bioinformatics. Although the biopharma segment dominated the market, its share decreased from 71% in 2006–2007 to 67% in 2007–2008, as revenue climbed 16% to $1.72 billion. Bioservices had the second largest share of sales with $370 million in revenue, and the fastest growth rate at 53%. The bioagri and bioindustrial segments grew 30% and 4% for 2007–2008, with revenues of $290 million and $100 million, respectively, while bioinformatics sales increased 31% to nearly $45 million. In 2015, total biotech revenues in India is estimated to be more than $15 billion, with biopharma accounting for nearly 40% of the market, or $6 billion, and the bioservices sector representing 9%, with $1.5 billion in sales.

Source: Biospectrum

< | >